7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Erasca Inc
(NASDAQ:ERAS) 

ERAS stock logo

Erasca is a clinical-stage, precision oncology company with a bold mission—to erase cancer. ... Our robust, rapidly advancing pipeline of promising therapeutic candidates has the potential to improve the treatment of a range of RAS/MAPK pathway-related cancers—and in turn, transform millions of live...

Founded: 2018
Full Time Employees: 102
CEO / Co-Founder: Jonathan E. Lim 
Sector:
Industry:

Share this website to your friends
Erasca Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 051.83103.67155.5207.34259.17311.01362.84
Erasca Days Inventory Outstanding ttm (DIO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4,687.94-4,018.24-3,348.53-2,678.82-2,009.12-1,339.41-669.710
Erasca Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.89-0.76-0.64-0.51-0.38-0.25-0.130
Erasca Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.09-0.94-0.78-0.62-0.47-0.31-0.160
Erasca Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.490.981.461.952.442.933.42
Erasca (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -6.81-5.84-4.86-3.89-2.92-1.95-0.970
Erasca P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.66-1.89-1.13-0.370.41.161.932.69
No extra charts and metrics for this ticker.